Methods for treatment or prophylaxis of kidney or liver dysfunction
AssigneeNPS Pharmaceuticals, Inc.
InventorsBo Joelsson, Henry H. Chu
Life of this patent
Estimating the term…
Abstract
Methods are provided for treatment or prophylaxis of liver or kidney dysfunction in individuals experiencing one or more of intestinal failure, short bowel syndrome or parenteral nutrition by the administration of GLP-2 or GLP-2 analogs.
Claims32
A method of treating impaired liver function in an individual experiencing intestinal failure, short bowel syndrome, or parenteral nutrition, comprising the step of administering to an individual having impaired liver function one or more of a GLP-2 peptide or a GLP-2 peptide analog in an amount effective to cause improvement in liver function.
A method for prophylaxis against impairment of liver function in an individual experiencing intestinal failure, short bowel syndrome, or parenteral nutrition, comprising the step of administering to an individual one or more of a GLP-2 peptide or a GLP-2 peptide analog in an amount effective for prophylaxis against impaired liver function.
A method of treating impaired kidney function in an individual experiencing intestinal failure, short bowel syndrome, or parenteral nutrition, comprising the step of administering to an individual having impaired kidney function one or more of a GLP-2 peptide or a GLP-2 peptide analog in an amount effective to cause improvement in kidney function.
A method for prophylaxis against impairment of kidney function in an individual experiencing intestinal failure, short bowel syndrome, or parenteral nutrition, comprising administering to an individual one or more of a GLP-2 peptide or a GLP-2 peptide analog in an amount effective for prophylaxis against impaired kidney function.
Dependencies are inferred from the claim text.